Previsioni di mercato dei vaccini per pesci nell\'Asia del Pacifico fino al 2030 - Analisi regionale - per tipo di vaccino (vaccini inattivati, vaccini vivi attenuati, vaccini a subunità, vaccino vettoriale ricombinante e altri), applicazione (infezione batterica, infezione virale e parassitaria), via di somministrazione ( vaccino per iniezione, vaccino per immersione e vaccino orale) e specie (salmone, trota, tilapia e altri)

BMIRE00029704 | Pages: 100 | Biotechnology | Feb 2024 | Type: Regional | Status: Published
Il mercato dei vaccini per pesci nell’Asia del Pacifico è stato valutato a 46,87 milioni di dollari nel 2022 e si prevede che raggiungerà i 94,15 milioni di dollari entro il 2030; si stima che crescerà a un CAGR del 9,1% dal 2022 al 2030.

Lo sviluppo di un nuovo vaccino per i pesci alimenta il mercato dei vaccini per i pesci nell\'Asia del Pacifico.

L\'emergenza di epidemie causate da parassiti, virus, e i batteri hanno rallentato l’evoluzione del settore dell’acquacoltura globale per diversi decenni. Oltre ad essere dannose per la salute umana, le malattie emergenti hanno un impatto significativo sugli animali acquatici. I vaccini tradizionali presentano limiti e inconvenienti, il che rafforza la domanda per lo sviluppo di nuovi vaccini avanzati come i vaccini multiepitopi chimerici. I progressi scientifici e tecnologici hanno aperto nuove strade nei campi della ricerca di base e applicata sui vaccini acquatici. È stato compiuto uno sforzo per creare nuovi vaccini acquatici con qualità ed efficienza più elevate utilizzando nuove tecnologie, approcci e strategie.

Utilizzando gli strumenti bioinformatici disponibili e le attuali conoscenze di immunoproteomica e genomica, i ricercatori possono identificare potenziali epitopi mirati che le cellule immunitarie possono riconoscere. Inoltre, poiché il costo di tecniche come il sequenziamento dell’intero genoma continua a diminuire, si apre la strada allo sviluppo di vaccini specie-specifici. Ciò probabilmente incrementerà gli investimenti nello sviluppo di nuovi vaccini. Nel 2021, il Central Institute of Brackishwater Aquaculture (ICAR) ha lanciato un vaccino ricombinante contro la necrosi nervosa virale (VNN) in India.

Pertanto, si prevede che lo sviluppo di un vaccino efficace per le mucose con il rafforzamento del processo di somministrazione accelererà lo sviluppo del nuovo vaccino, che stimolerebbe le imprese di acquacoltura nei paesi del Mediterraneo a regolarizzare i processi di vaccinazione dei pesci. Pertanto, lo sviluppo di nuovi vaccini per i pesci probabilmente creerà significative opportunità di crescita del mercato.

Panoramica del mercato dei vaccini per pesci nell\'Asia del Pacifico

Il mercato dei vaccini per i pesci nell\'Asia del Pacifico è segmentato in Cina, Giappone, India, Corea del Sud, Australia e nel resto dell\'Asia del Pacifico. La crescita del mercato in questi paesi è attribuita al crescente settore dell’acquacoltura nella regione e alle iniziative governative favorevoli. Inoltre, si prevede che le strategie di espansione e di lancio dei prodotti implementate dagli operatori del mercato contribuiranno alla crescita del mercato dei vaccini per pesci nella regione. La produzione dell’acquacoltura commerciale in Giappone si è sviluppata notevolmente dalla fine della Seconda Guerra Mondiale e occupa un posto importante nel settore della pesca. Più di 60 specie sono incluse nella sezione acquacoltura delle statistiche annuali sulla pesca. Di queste, le specie principali sono nori, capesante, ostriche, ricciole giapponesi, saraghi e senape di mare. Tuttavia, la domanda interna di prodotti ittici diminuirà nel prossimo decennio, e anche la produzione dell’acquacoltura diminuirà se continuerà a dipendere dalla domanda interna. Questo calo della domanda in Giappone è dovuto al fatto che la popolazione giapponese sta diminuendo e la loro dieta si sta spostando verso la carne.

Entrate e previsioni del mercato dei vaccini per pesci nell\'Asia del Pacifico fino al 2030 (milioni di dollari)

Segmentazione del mercato dei vaccini per i pesci nell\'Asia del Pacifico

Il mercato dei vaccini per i pesci nell\'Asia del Pacifico è segmentato in base al vaccino tipo, applicazione, via di somministrazione, specie e paese.

In base al tipo di vaccino, il mercato dei vaccini per pesci nell\'Asia Pacifico è segmentato in vaccini inattivati, vaccini vivi attenuati, vaccini a subunità, vaccini vettoriali ricombinanti e altri. Il segmento dei vaccini inattivati ha detenuto la quota di mercato maggiore nel 2022.

In base all\'applicazione, il mercato dei vaccini per pesci nell\'Asia del Pacifico è segmentato in infezione batterica, infezione virale e parassitaria. Il segmento delle infezioni batteriche ha detenuto la quota di mercato maggiore nel 2022.

In base alla via di somministrazione, il mercato dei vaccini per pesci nell\'Asia del Pacifico è segmentato in vaccino iniettabile, vaccino per immersione e vaccino orale. Il segmento dei vaccini iniettabili ha detenuto la quota di mercato maggiore nel 2022.

In base alle specie, il mercato dei vaccini per pesci nell\'Asia del Pacifico è segmentato in salmone, trota, tilapia e altri. Il segmento del salmone ha detenuto la quota di mercato maggiore nel 2022.

In base al paese, il mercato dei vaccini per pesci nell\'Asia del Pacifico è segmentato in Cina, Giappone, India, Australia, Corea del Sud e resto dell\'Asia del Pacifico. Il Giappone ha dominato la quota di mercato dei vaccini per pesci nell\'Asia del Pacifico nel 2022.

Choong Ang Vaccine Laboratories Co.; Elanco Animal Health Inc; Hipra SA; IMMUNOLOGICI INDIANI LTD; KBNP Inc.; Laboratori Biken di Kyoto; Merck & Co Inc.; Nisseiken Co., Ltd.; Phibro Animal Health Corp; Vaxxinova Internazionale BV; e Zoetis Inc. sono alcune delle aziende leader che operano nel mercato dei vaccini per pesci nell\'Asia del Pacifico.

Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Asia Pacific Fish Vaccine Market
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Fish Vaccine Market - Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Government Initiatives to Develop Aquaculture Industry
4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:
5. Fish Vaccine Market - Asia Pacific Market Analysis
5.1 Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
6. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Vaccine Type
6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
6.3.1 Overview
6.3.2 Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
6.4.1 Overview
6.4.2 Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
6.5.1 Overview
6.5.2 Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
6.6.1 Overview
6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
6.7.1 Overview
6.7.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
7.3.1 Overview
7.3.2 Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
7.4.1 Overview
7.4.2 Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
7.5.1 Overview
7.5.2 Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Route of Administration
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
8.3.1 Overview
8.3.2 Injection vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
8.4.1 Overview
8.4.2 Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9. Asia Pacific Fish Vaccine Market - Revenue and Forecast to 2030 - by Species
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
9.3.1 Overview
9.3.2 Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
9.4.1 Overview
9.4.2 Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
9.5.1 Overview
9.5.2 Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
10. Asia Pacific Fish Vaccine Market - Country Analysis
10.1 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.2 Asia Pacific Fish Vaccine Market, by Country
10.1.2.1 China
10.1.2.1.1 Overview
10.1.2.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.1.4 China: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.1.5 China: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.1.6 China: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.2 Japan
10.1.2.2.1 Overview
10.1.2.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.2.5 Japan: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.2.6 Japan: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.3 India
10.1.2.3.1 Overview
10.1.2.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.3.4 India: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.3.5 India: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.3.6 India: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.4 Australia
10.1.2.4.1 Overview
10.1.2.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.4.5 Australia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.4.6 Australia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.5 South Korea
10.1.2.5.1 Overview
10.1.2.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.5.5 South Korea: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.5.6 South Korea: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.2.6 Rest of Asia Pacific
10.1.2.6.1 Overview
10.1.2.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.2.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.2.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.2.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.2.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
11. Fish Vaccine Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Zoetis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HIPRA SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phibro Animal Health Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vaxxinova International BV
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Kyoto Biken Laboratories Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Elanco Animal Health Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nisseiken Co Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 KBNP Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Choong Ang Vaccine Laboratory
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Indian Immunologicals Ltd
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms



List of Tables
Table 1. Asia Pacific Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. China Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 8. China Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 9. China Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 10. China Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 11. Japan Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 12. Japan Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 13. Japan Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 14. Japan Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 15. India Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 16. India Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 17. India Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 18. India Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Australia Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Australia Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Australia Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Australia Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 23. South Korea Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 24. South Korea Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 25. South Korea Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 26. South Korea Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 27. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type - Revenue and Forecast to 2030 (US$ Thousand)
Table 28. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration - Revenue and Forecast to 2030 (US$ Thousand)
Table 29. Rest of Asia Pacific Fish Vaccine Market, by Species - Revenue and Forecast to 2030 (US$ Thousand)
Table 30. Rest of Asia Pacific Fish Vaccine Market, by Application - Revenue and Forecast to 2030 (US$ Thousand)
Table 31. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 32. Recent Organic Growth Strategies in Fish Vaccine Market
Table 33. Glossary of Terms, Asia Pacific Fish Vaccine Market

List of Figures
Figure 1. Asia Pacific Fish Vaccine Market Segmentation, By Country
Figure 2. Asia Pacific Fish Vaccine Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Fish Vaccine Market Revenue (US$ Th), 2022 - 2030
Figure 5. Asia Pacific Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Asia Pacific Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Asia Pacific Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market - Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Asia Pacific Fish Vaccine Market, by Key Country - Revenue, 2022 (US$ Thousand)
Figure 25. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 31. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 32. Growth Strategies in Fish Vaccine Market

1. Choong Ang Vaccine Laboratories Co.
2. Elanco Animal Health Inc
3. Hipra SA
4. INDIAN IMMUNOLOGICALS LTD
5. KBNP Inc.
6. Kyoto Biken Laboratories
7. Merck & Co Inc.
8. Nisseiken Co., Ltd.
9. Phibro Animal Health Corp
10. Vaxxinova International BV
11. Zoetis Inc.

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific fish vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific fish vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific fish vaccines market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440